ZEENA PATEL: Open Payments
NPI 1376215814 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,485 in 48 payments from 8 companies in 2025. Trend: 2023 $496 · 2024 $3,448 · 2025 $8,485
Consulting: $6,500Food & beverage: $1,673Travel & lodging: $312
| Company | Payments | Amount |
|---|---|---|
| Intrinsic Therapeutics | 28 | $6,867 |
| Abbott Laboratories | 12 | $1,129 |
| SI-BONE, INC. | 3 | $239 |
| Stryker Corporation | 1 | $166 |
| Heron Therapeutics, Inc. | 1 | $27 |
| Bioventus LLC | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Biocomposites Inc | 1 | $18 |
Products named: BARRICAID ACD (ANNULAR CLOSURE DEVICE), PROCLAIM, MAKO, ETERNA, ZYNRELEF, XCELL, JOURNAVX, Stimulan.
Industry payments across TX — which companies pay providers there.
